⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7523837 | 1.00 | — | — | |
| SCHEMBL7517483 | 1.00 | — | — | |
| SCHEMBL7519012 | 1.00 | — | — | |
| SCHEMBL7519143 | 1.00 | — | — | |
| SCHEMBL7520039 | 0.73 | — | — | |
| SCHEMBL7520722 | 0.73 | — | — | |
| SCHEMBL7524682 | 0.73 | — | — | |
| SCHEMBL7525516 | 0.73 | — | — | |
| SCHEMBL7520037 | 0.73 | — | — | |
| SCHEMBL7517082 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3679030-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | Cadila Healthcare Limited (IN) | 2020-07-15 | — | — | EP | claimed |
| US-20200207738-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2020-07-02 | — | — | US | claimed |
| CN-111051299-A | Preparation method of triaminopyrimidine compound and intermediate thereof | 卡迪拉保健有限公司 | 2020-04-21 | — | — | CN | claimed |
| WO-2019049021-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2019-03-14 | — | — | WO | claimed |
| US-12378223-B2 | Process for preparation of triaminopyrimidine compound and intermediates thereof | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-08-05 | — | — | US | disclosed |
| EP-3679030-B1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | ZYDUS LIFESCIENCES LTD (IN) | 2024-03-27 | — | — | EP | disclosed |
| EP-3679030-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | Cadila Healthcare Limited (IN) | 2020-07-15 | — | — | EP | disclosed |
| US-20200207738-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2020-07-02 | — | — | US | disclosed |
| CN-111051299-A | Preparation method of triaminopyrimidine compound and intermediate thereof | 卡迪拉保健有限公司 | 2020-04-21 | — | — | CN | disclosed |
| WO-2019049021-A1 | A PROCESS FOR PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND INTERMEDIATES THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2019-03-14 | — | — | WO | disclosed |
| US-20020042055-A1 | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions | MAXYGEN, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001046476-A1 | ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS | MAXYGEN, INC. (US) | 2001-06-28 | — | — | WO | disclosed |
| US-4517183-A | COMBATING DISEASES WITH WEAKNESS OF IMMUNE SYSTEMS | BOEHRINGER MANNHEIM GMBH (DE) | 1985-05-14 | — | — | US | disclosed |
| US-4397848-A | ANTITUMOR ACTIVITY | BOEHRINGER MANNHEIM GMBH (DE) | 1983-08-09 | — | — | US | disclosed |
| US-4282212-A | Immune-stimulating 1-(N-acylcarbamoyl)-2-cyanoaziridines | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-04 | — | — | US | disclosed |
| EP-0014976-A1 | N-substituted 2-cyanaziridines, methods for their preparation and medicaments containing them, correspondingly substituted aziridine-2-carbonamides and their preparation | Roche Diagnostics GmbH (DE) | 1980-09-03 | — | — | EP | disclosed |